Beta-hexosaminidase Release
Beta-hexosaminidase Release - Related Videos
03:08
Fabrication of Amyloid-Beta-Releasing Polymer Microbeads for Modeling Alzheimer's Disease
0 Views •
2025
This video demonstrates a method for fabricating polymer microbeads that encapsulate neurotoxic amyloid-beta-secreting cells. The cell-polymer suspension is processed through a microbead fabrication device, with polymer gelation achieved via calcium cross-linking, forming spherical microbeads around the cells. The polymer allows cell proliferation while allowing controlled, long-term amyloid-beta release, simulating its accumulation in Alzheimer's disease.
05:39
Humanized Mediator Enzyme Release Assay: An Immunochemical Method to Screen Allergic Potential of Test Antigen by Monitoring Basophil Degranulation Response In Vitro
0 Views •
2025
In this video, we describe an in vitro method to evaluate the allergic potential of an antigen to induce basophil degranulation. β-hexosaminidase is used as an index of chemical mediator release, and the enzyme activity of β-hexosaminidase is measured using a fluorogenic substrate.
01:25
Beta
0 Views •
2024
Beta is a crucial metric in finance used to assess an investment's risk and expected return relative to the overall market. It is calculated as the slope of the line in a scatterplot that compares the returns of an individual stock to the returns of the market benchmark, typically represented by a broad market index. Beta quantifies how much a stock's price moves in response to market movements, providing insight into its volatility and systematic risk. A beta of one indicates that the stock's...
12:12
Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes
0 Views •
Cited by 14 •
2011
Cell-mediated lymphocytotoxicity (CML) assays can be used to test autoreactive responses and study mechanisms of cell death in vitro. However, using live-cell confocal microscopic imaging techniques with fluorescent dyes, the type and kinetics of cell death as well as the pathways utilized can be studied in greater detail.
04:16
Imaging Transgenic Beta-Cells in an Immunodeficient Mouse Challenged with Diabetic Splenocytes
0 Views •
2025
This video demonstrates an imaging-based method to visualize transplanted luciferase-expressing beta cells into a non-obese diabetic immunodeficient mouse. The introduction of splenocytes from a diabetic mouse leads to progressive beta cell destruction, visually confirmed by declining luminescence after substrate introduction.
FAQs
Activation-dependent signaling initiates fusion of cytoplasmic granules with the plasma membrane. This membrane fusion transfers granule contents into the surrounding medium, allowing secretory activity to be assessed outside the cell. In immunology experiments, the event connects an upstream immune stimulus with a measurable degranulation response.
Colorimetric and fluorogenic substrates provide two readout formats for enzyme activity. The reaction produces either a color change or fluorescence, and the resulting signal can be quantified in the surrounding medium. This makes beta-hexosaminidase release suitable for comparing secretory responses across activated immune-cell conditions.
Greater measured activity generally indicates that more beta-hexosaminidase has reached the medium, consistent with stronger degranulation under the tested conditions. Comparing this signal after exposure to allergens, pathogens, immune mediators, or candidate drugs helps determine whether those conditions enhance or reduce secretory activity. The result provides a practical measure of the cellular secretory response.
A basic workflow begins by exposing immune cells to the stimulus under investigation, then examining the surrounding medium for released enzyme activity. Researchers add a colorimetric or fluorogenic substrate and quantify the resulting signal. The measured value provides an assay readout for degranulation, enabling allergens, pathogens, mediators, or drugs to be evaluated in a common experimental framework.
It provides a direct experimental readout of secretory activity in mast cells and basophils, two immune-cell populations highlighted for this application. By measuring enzyme activity after exposure to an allergen, pathogen, immune mediator, or candidate drug, investigators can compare how each condition affects degranulation and identify changes relevant to inflammatory responses or drug-mediated inhibition.
In infection research, the assay helps examine how immune-cell secretion changes in response to pathogens and immune mediators. Those measurements support analysis of host-pathogen interactions, while comparisons involving candidate drugs can reveal potential suppression of excessive immune activation. Linking enzyme release to these broader questions makes the assay useful for connecting cellular degranulation with inflammation and therapeutic investigation.